Related references
Note: Only part of the references are listed.Cost-effectiveness of Argatroban Versus Heparin Anticoagulation in Adult Extracorporeal Membrane Oxygenation Patients
Angelina E. Cho et al.
HOSPITAL PHARMACY (2021)
Venoarterial-Extracorporeal Membrane Oxygenation Without Routine Systemic Anticoagulation Decreases Adverse Events
Katherine L. Wood et al.
ANNALS OF THORACIC SURGERY (2020)
Preoperative and intraoperative argatroban as anticoagulant for bridging a patient with heparin-induced thrombocytopaenia to lung transplantation
Dong Kyu Oh et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2020)
Argatroban dosing requirements in extracorporeal life support and other critically ill populations
J. Spencer Dingman et al.
THROMBOSIS RESEARCH (2020)
A 24-hour perioperative case study on argatroban use for left ventricle assist device insertion during cardiopulmonary bypass and veno-arterial extracorporeal membrane oxygenation
Philip Fernandes et al.
PERFUSION-UK (2019)
Vanishing Wor(l)ds
Markus K. Heinemann
THORACIC AND CARDIOVASCULAR SURGEON (2019)
Heparin-induced thrombocytopenia during extracorporeal life support: incidence, management and outcomes
Jae Hwan Choi et al.
ANNALS OF CARDIOTHORACIC SURGERY (2019)
Argatroban and Bivalirudin for Perioperative Anticoagulation in Cardiac Surgery
Andreas Koster et al.
ANESTHESIOLOGY (2018)
Extracorporeal membrane oxygenation in severe respiratory failure resulting from burns and smoke inhalation injury
Lajos Szentgyorgyi et al.
BURNS (2018)
Heart transplant after profoundly extended ambulatory central venoarterial extracorporeal membrane oxygenation
Yasuhiro Shudo et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2018)
Prevalence and outcome of heparin-induced thrombocytopenia diagnosed under veno-arterial extracorporeal membrane oxygenation: a retrospective nationwide study
Antoine Kimmoun et al.
INTENSIVE CARE MEDICINE (2018)
Use of argatroban for extracorporeal life support in patients with nonheparin-induced thrombocytopenia Analysis of 10 consecutive patients
Young Su Kim et al.
MEDICINE (2018)
Novel Surfaces in Extracorporeal Membrane Oxygenation Circuits
Andrea Ontaneda et al.
FRONTIERS IN MEDICINE (2018)
Monitoring of Argatroban and Lepirudin: What is the Input of Laboratory Values in Real Life?
Holger Seidel et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2018)
Bivalirudin for Alternative Anticoagulation in Extracorporeal Membrane Oxygenation: A Systematic Review
Filippo Sanfilippo et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2017)
Argatroban in Thrombocytopenic Patients Sensitized to Circulating Protamine-Heparin Complexes
Patricia Pia Wadowski et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2017)
Anticoagulation and Transfusion Therapy in Patients Requiring Extracorporeal Membrane Oxygenation
Jesse M. Raiten et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2017)
Heparin induced thrombocytopenia with mechanical circulatory support devices: review of the literature and management considerations
Jonathan Bain et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)
Efficacy and safety of argatroban in patients with acute respiratory distress syndrome and extracorporeal lung support
Mario Menk et al.
ANNALS OF INTENSIVE CARE (2017)
Argatroban for an alternative anticoagulant in HIT during ECMO
Alain Rouge et al.
JOURNAL OF INTENSIVE CARE (2017)
Runtime and aPTT predict venous thrombosis and thromboembolism in patients on extracorporeal membrane oxygenation: a retrospective analysis
Franziska C. Trudzinski et al.
ANNALS OF INTENSIVE CARE (2016)
Anticoagulation for Extracorporeal Life Support: Direct Thrombin Inhibitors and Heparin
Megan A. Coughlin et al.
ASAIO JOURNAL (2015)
Safety Profile of Argatroban vs Heparin for Anticoagulation in Patients Requiring Extra Corporeal Membrane Oxygenation (ECMO) Therapy
Killol Patel et al.
CHEST (2015)
Implantation of left ventricular assist devices under extracorporeal life support in patients with heparin-induced thrombocytopenia
Julia Hillebrand et al.
JOURNAL OF ARTIFICIAL ORGANS (2015)
Progressive, Fatal Thrombosis Associated With Heparin-Induced Thrombocytopenia After Cardiac Surgery Despite Therapeutic Anticoagulation With Argatroban: Potential Role for PTT and ACT Confounding
Maureen A. Smythe et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2015)
Extracorporeal Membrane Oxygenation in the Adult: A Review of Anticoagulation Monitoring and Transfusion
Stephen A. Esper et al.
ANESTHESIA AND ANALGESIA (2014)
The dosing and monitoring of argatroban for heparin-induced thrombocytopenia during extracorporeal membrane oxygenation: a word of caution
M. R. Phillips et al.
ANAESTHESIA AND INTENSIVE CARE (2014)
Successful treatment of pulmonary-renal syndrome in HIT-positive patient using ECM with argatroban
Mark Caridi-Scheible et al.
CRITICAL CARE MEDICINE (2013)
Fatal HIT in CV surgery patient on ECMO: Argatroban failure or argatroban monitoring failure?
Lisa Forsyth et al.
CRITICAL CARE MEDICINE (2013)
Bivalirudin and post-cardiotomy ECMO: a word of caution
Marco Ranucci
CRITICAL CARE (2012)
Coagulation management in patients undergoing mechanical circulatory support
Klaus Goerlinger et al.
BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY (2012)
Direct thrombin inhibitors
Catherine J. Lee et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Direct thrombin inhibitors: pharmacology and application in intensive care medicine
Eva Schaden et al.
INTENSIVE CARE MEDICINE (2010)
Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study
Bernd Saugel et al.
CRITICAL CARE (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Treatment and prevention of heparin-induced thrombocytopenia
Theodore E. Warkentin et al.
CHEST (2008)
Argatroban Anticoagulation in Intensive Care Patients: Effects of Heart Failure and Multiple Organ System Failure
Susan M. Begelman et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2008)
A case series describing the use of argatroban in patients on extracorporeal circulation
Timothy Cornell et al.
ASAIO JOURNAL (2007)
Argatroban in extracorporeal membrane oxygenation
Martin Beiderlinden et al.
ARTIFICIAL ORGANS (2007)
Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia
Louis M. Guzzi et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2006)
Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia
IY Tang et al.
ANNALS OF PHARMACOTHERAPY (2005)
Argatroban dosing in intensive care patients with acute renal failure and liver dysfunction
DR Williamson et al.
PHARMACOTHERAPY (2004)
Argatroban as an alternative to heparin in extracorporeal membrane oxygenation circuits
G Young et al.
PERFUSION-UK (2004)
Excessive argatroban anticoagulation for heparin-induced thrombocytopenia
MG Reichert et al.
ANNALS OF PHARMACOTHERAPY (2003)
Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients
SG Sakka et al.
CHEST (2002)
Clinical application of argatroban as an alternative anticoagulant for extracorporeal circulation
T Kawada et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2000)
The pharmacokinetics and pharmacodynamics of argatroban: Effects of age, gender, and hepatic or renal dysfunction
SK Swan et al.
PHARMACOTHERAPY (2000)
Share Paper
